Datamonitor, Jan 2009
the companys R&D pipeline, historical financial data and product profiles.
Key reasons to purchase this title
- Access key forecast product sales for Wyeth
- View the companys financial statements
Datamonitor, Nov 2010, Pages: 122
Threats
ABOUT THIS PROFILEPharmaVitae Explorer database
Chapter structure
Quarterly update
Company introduction
Company sales
Company financials
Key products
Data
Datamonitor, June 2010, Pages: 105
Company, Inc.
Johnson & Johnson
Kirin Brewery Holdings Company, Limited
Medicines Company, The
OPG Groep
Pfizer Inc
Wyeth Amgen Inc.: PharmaVitaeProfile
Datamonitor, March 2011, Pages: 84
an imminent wave of generic compeitition.
- Assess what makes BMS a model biopharma company and why its newfound focus could lead to the industry's next megamerger ABOUT THIS PROFILE
- PharmaVitae Explorer
Datamonitor, June 2010, Pages: 116
enhanced the company's HealthCare division
-Assess how an increased healthcare focus and merger-related synergies will drive an increase in operating profit
Chapter 1 About this profilePharmaVitae
Datamonitor, Aug 2008, Pages: 244
within the PharmaVitae Rx pharma universe
- Evaluation of permutations from a perspective of the targets uplift of the acquirers sales growth rate between 2007 and 2012
- Relate this uplift
Datamonitor, March 2009, Pages: 134
., Inc.
Nektar Therapeutics
Nycomed International Management GmbH
Pfizer Inc
Safety Insurance Group, Inc.
Sepracor Inc.
Servier
Solvay Group
Wyeth Solvay S.A.: PharmaVitaeProfile
Datamonitor, Dec 2009, Pages: 114
has classified each of the current Big Pharma players by their dominant M&A growth strategy
- Analyze the M&A and organic sales growth profiles for each Big Pharma company over the period 1995
